Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets

Ovarian cancer remains the most fatal gynecologic malignancy worldwide due to delayed diagnosis as well as recurrence and drug resistance. Thus, the development of new tumor-related molecules with high sensitivity and specificity to replace or supplement existing tools is urgently needed. Cancer-tes...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Kaipeng, Fu, Chenyang, Wang, Suli, Xu, Hanzi, Liu, Siyu, Shao, Yang, Gong, Zhen, Wu, Xiaoli, Xu, Bo, Han, Jing, Xu, Juan, Xu, Pengfei, Jia, Xuemei, Wu, Jiangping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318940/
https://www.ncbi.nlm.nih.gov/pubmed/30609934
http://dx.doi.org/10.1186/s13048-018-0475-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318940/
https://www.ncbi.nlm.nih.gov/pubmed/30609934
http://dx.doi.org/10.1186/s13048-018-0475-z

Ejemplares similares